HCA
BLFS icon

Harbour Capital Advisors’s BioLife Solutions BLFS Stock Holding History

Harbour Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,650
Closed -$361K – 276
2024
Q4 		$361K Buy
+13,650
New +$340K 0.08% 209

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Harbour Capital Advisors's BLFS Position: Q1 2025 in Review

Harbour Capital Advisors sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 13,650 shares — an estimated $361K sold.

Harbour Capital Advisors first reported a position in BLFS in Q4 2024 and held it in 1 quarter. The position peaked at $361K in Q4 2024. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • Harbour Capital Advisors reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
  • Harbour Capital Advisors sold 13,650 BioLife Solutions shares in Q1 2025, an estimated $361K.
  • Harbour Capital Advisors first reported a position in BioLife Solutions in Q4 2024 and held it in 1 quarter.
  • Harbour Capital Advisors's BioLife Solutions position peaked at $361K in Q4 2024.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on Harbour Capital Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.